Polymeric micelles and nanoemulsions as drug carriers: Therapeutic efficacy, toxicity, and drug resistance

Journal of Controlled Release

Volumn 212, Issue , 2015, Pages 70-77

  Gupta, Roohi ^a,d   Shea, Jill ^b   Scafe, Courtney ^b   Shurlygina, Anna ^c   Rapoport, Natalya ^a  

^a University of Utah   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

Drug resistance; Hematological toxicity; Nanoemulsions; Paclitaxel; Poly(ethylene oxide) co poly(d,l lactide); Poly(ethylene oxide) co poly(l lactide); Polymeric micelles; Tumor recurrence

Indexed keywords

BIODEGRADATION; BLOCK COPOLYMERS; COPOLYMERS; DRUG THERAPY; ETHYLENE; FUNCTIONAL POLYMERS; MAMMALS; MICELLES; MICROBIOLOGY; PHARMACOKINETICS; POLYESTERS; POLYETHYLENE GLYCOLS; POLYMERS; TOXICITY; TUMORS;

DRUG RESISTANCE; NANO-EMULSIONS; PACLITAXEL; POLY (D ,L-LACTIDE); POLY (L-LACTIDE); POLYMERIC MICELLE; TUMOR RECURRENCES;

POLYETHYLENE OXIDES;

COPOLYMER; DRUG CARRIER; PACLITAXEL; POLY(ETHYLENE OXIDE) CO POLYLACTIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; EMULSION; MACROGOL DERIVATIVE; MICELLE; NANOMATERIAL; POLYESTER; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TOXICITY; CANCER RESISTANCE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; ECHOGRAPHY; HYDROPHOBICITY; MALE; MICELLE; MOUSE; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PANCREAS CANCER; PARTICLE SIZE; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; EMULSION; HUMAN; LEUKOCYTE; NUDE MOUSE; PANCREAS; PANCREATIC NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG CARRIERS; DRUG RESISTANCE, NEOPLASM; EMULSIONS; HUMANS; LEUKOCYTES; MALE; MICE, NUDE; MICELLES; NANOSTRUCTURES; PACLITAXEL; PANCREAS; PANCREATIC NEOPLASMS; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 84934945059     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.06.019     Document Type: Article

References (34)

1. P.M. Winter, K. Cai, S.D. Caruthers, S.A. Wickline, and G.M. Lanza Emerging nanomedicine opportunities with perfluorocarbon nanoparticles Expert Rev. Med. Devices 4 2007 137 145
2. H.F. Zhou, H.W. Chan, S.A. Wickline, G.M. Lanza, and C.T. Pham Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice FASEB J. 23 2009 2978 2985
3. Z. Gao, A.M. Kennedy, D.A. Christensen, and N.Y. Rapoport Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy Ultrasonics 48 2008 260 270
4. N. Rapoport Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 492 510
5. N. Rapoport Ultrasound-mediated micellar drug delivery Int. J. Hyperthermia 28 2012 374 385
6. N. Rapoport, A. Payne, C. Dillon, J. Shea, A.R. Scaife, and R. Gupta Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model J. Ther. Ultrasound 1 2013
7. N. Rapoport, Z. Gao, and A. Kennedy Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy J. Natl. Cancer Inst. 99 2007 1095 1106
8. N. Rapoport Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery Prog. Polym. Sci. 32 2007 962 990
9. R.R. Sawant, and V.P. Torchilin Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example Methods Mol. Biol. 624 2010 131 149
10. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S81 S91
11. V.P. Torchilin Targeted polymeric micelles for delivery of poorly soluble drugs Cell. Mol. Life Sci. 61 2004 2549 2559
12. Y. Kakizawa, and K. Kataoka Block copolymer micelles for delivery of gene and related compounds Adv. Drug Deliv. Rev. 54 2002 203 222
13. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
14. Y. Matsumura, M. Yokoyama, K. Kataoka, T. Okano, Y. Sakurai, T. Kawaguchi, and T. Kakizoe Reduction of the side effects of an antitumor agent, KRN5500, by incorporation of the drug into polymeric micelles Jpn. J. Cancer Res. 90 1999 122 128
15. Y. Yamamoto, Y. Nagasaki, Y. Kato, Y. Sugiyama, and K. Kataoka Long-circulating poly(ethylene glycol)-poly(D, L-lactide) block copolymer micelles with modulated surface charge J. Control. Release 77 2001 27 38
16. E. Fournier, M.H. Dufresne, D.C. Smith, M. Ranger, and J.C. Leroux A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers Pharm. Res. 21 2004 962 968
17. T.Y. Kim, D.W. Kim, J.Y. Chung, S.G. Shin, S.C. Kim, D.S. Heo, N.K. Kim, and Y.J. Bang Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin. Cancer Res. 10 2004 3708 3716
18. D. Le Garrec, S. Gori, L. Luo, D. Lessard, D. Smith, and M.E.A. Yessine Poly(n-vinylpyrrolidone)-block-poly(d, l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation J. Control. Release 99 2004 83 101
19. J.G. Kim, S.K. Sohn, H.S. Song, K.Y. Kwon, Y.R. Do, K.H. Lee, M.S. Hyun, H.M. Ryoo, S.H. Bae, K.U. Park, J.H. Baek, W.S. Lee, J.S. Chung, G.J. Cho, C.H. Sohn, J.S. Jang, H.Y. Chung, and W. Yu Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer Cancer Chemother. Pharmacol. 60 2007 863 869
20. K.S. Lee, H.C. Chung, S.A. Im, Y.H. Park, C.S. Kim, S.B. Kim, S.Y. Rha, M.Y. Lee, and J. Ro Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Breast Cancer Res. Treat. 108 2008 241 250
21. M.W. Saif, N.A. Podoltsev, M.S. Rubin, J.A. Figueroa, M.Y. Lee, J. Kwon, E. Rowen, J. Yu, and R.O. Kerr Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer Cancer Investig. 28 2010 186 194
22. Y. Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, Y. Shimada, K. Shirao, T. Okusaka, H. Ueno, M. Ikeda, and N. Watanabe Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin Br. J. Cancer 91 2004 1775 1781
23. N. Rapoport Stabilization and acoustic activation of Pluronic micelles for tumor-targeted drug delivery Colloids Surf. B 3 1999 93 111
24. H.C. Shin, H. Cho, T.C. Lai, K.R. Kozak, J.M. Kolesar, and G.S. Kwon Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin J. Control. Release 163 2012 93 99
25. N.Y. Rapoport, A.M. Kennedy, J.E. Shea, C.L. Scaife, and K.-H. Nam Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles J. Control. Release 138 2009 268 276
26. N. Rapoport, K.-H. Nam, R. Gupta, Z. Gao, P. Mohan, A. Payne, N. Todd, X. Liu, T. Kim, J. Shea, C. Scaife, A.M. Kennedy, D.L. Parker, and E.-K. Jeong Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions J. Control. Release 153 2011 4 15
27. M.J. Torgenson, J.E. Shea, M.A. Firpo, Q. Dai, S.J. Mulvihill, and C.L. Scaife Natural history of pancreatic cancer recurrence following "curative" resection in athymic mice J. Surg. Res. 149 2008 57 61
28. N. Rapoport, R. Gupta, Y.S. Kim, and B.E. O'Neill Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: insight through intravital imaging J. Control. Release 206 2015 153 160
29. D.Y. Alakhova, N.Y. Rapoport, E.V. Batrakova, A.A. Timoshin, S. Li, D. Nicholls, V.Y. Alakhov, and A.V. Kabanov Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers J. Control. Release 142 2010 89 100
30. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2008 98 106
31. E.V. Batrakova, S. Li, V.Y. Alakhov, W.F. Elmquist, D.W. Miller, and A.V. Kabanov Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85 Pharm. Res. 20 2003 1581 1590
32. E.V. Batrakova, S. Li, A.M. Brynskikh, A.K. Sharma, Y. Li, M. Boska, N. Gong, R.L. Mosley, V.Y. Alakhov, H.E. Gendelman, and A.V. Kabanov Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers J. Control. Release 143 2010 290 301
33. N.Y. Rapoport, A.L. Efros, D.A. Christensen, A.M. Kennedy, and K.H. Nam Microbubble generation in phase-shift nanoemulsions used as anticancer drug carriers Bub Sci. Eng. Technol. 1 2009 31 39
34. B.E. O'Neill, and N. Rapoport Phase-shift, stimuli-responsive drug carriers for targeted delivery Ther. Deliv. 2 2011 1165 1187